Cargando…

Herbal Therapy for the Treatment of Acetaminophen-Associated Liver Injury: Recent Advances and Future Perspectives

Acetaminophen (APAP) overdose is the leading cause of drug-induced liver injury worldwide, and mitochondrial oxidative stress is considered the major event responsible for APAP-associated liver injury (ALI). Despite the identification of N-acetyl cysteine, a reactive oxygen species scavenger that is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Ling, Xu, Dongwei, Zhu, Jianjun, Ge, Guangbo, Kong, Xiaoni, Zhou, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078345/ https://www.ncbi.nlm.nih.gov/pubmed/32218738 http://dx.doi.org/10.3389/fphar.2020.00313

Ejemplares similares

Advances in the study of acetaminophen-induced liver injury
por: Li, Xinghui, et al.
Publicado: (2023)

Corrigendum: Advances in the study of acetaminophen-induced liver injury
por: Li, Xinghui, et al.
Publicado: (2023)

Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury
por: Huang, Ping, et al.
Publicado: (2022)

Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
por: Pu, Shiyun, et al.
Publicado: (2019)

Fisetin Prevents Acetaminophen-Induced Liver Injury by Promoting Autophagy
por: Zhang, Jiaqi, et al.
Publicado: (2020)

Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
por: Weiskirchen, Ralf
Publicado: (2019)

Recent Advances in Herbal Medicines for Digestive System Malignancies
por: Sheng, Jiyao, et al.
Publicado: (2018)

Apigenin Prevents Acetaminophen-Induced Liver Injury by Activating the SIRT1 Pathway
por: Zhao, Licong, et al.
Publicado: (2020)

N-Acetylcysteine for Preventing Acetaminophen-Induced Liver Injury: A Comprehensive Review
por: Licata, Anna, et al.
Publicado: (2022)

Acetaminophen-induced liver injury: Molecular mechanism and treatments from natural products
por: Liao, Jiaqing, et al.
Publicado: (2023)

The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches
por: Xu, Dongwei, et al.
Publicado: (2019)

Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver
por: Rivera, Patricia, et al.
Publicado: (2017)

Advancements and future prospective of DNA barcodes in the herbal drug industry
por: Mahima, Karthikeyan, et al.
Publicado: (2022)

Midazolam Ameliorates Acute Liver Injury Induced by Carbon Tetrachloride via Enhancing Nrf2 Signaling Pathway
por: Zhang, Yongyan, et al.
Publicado: (2022)

Quercitrin Attenuates Acetaminophen-Induced Acute Liver Injury by Maintaining Mitochondrial Complex I Activity
por: Xiong, Weichen, et al.
Publicado: (2021)

Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives
por: Jin, Qiang, et al.
Publicado: (2022)

Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives
por: Fu, Siyu, et al.
Publicado: (2020)

N-Acetylcysteine for the Management of Non-Acetaminophen Drug-Induced Liver Injury in Adults: A Systematic Review
por: Sanabria-Cabrera, Judith, et al.
Publicado: (2022)

Chinese Herbal Medicine for Primary Liver Cancer Therapy: Perspectives and Challenges
por: Li, Kexin, et al.
Publicado: (2022)

Cardamonin Reduces Acetaminophen-Induced Acute Liver Injury in Mice via Activating Autophagy and NFE2L2 Signaling
por: Xu, Qiushi, et al.
Publicado: (2020)

Cajaninstilbene Acid Ameliorates Acetaminophen-Induced Liver Injury Through Enhancing Sestrin2/AMPK-Mediated Mitochondrial Quality Control
por: Yan, Mingzhu, et al.
Publicado: (2022)

Simulation of the crosstalk between glucose and acetaminophen metabolism in a liver zonation model
por: Maeda, Kazuhiro, et al.
Publicado: (2022)

Kidney Injury Following Ibuprofen and Acetaminophen: A Real-World Analysis of Post-Marketing Surveillance Data
por: Shao, Qi-hui, et al.
Publicado: (2021)

IPF-Acute Exacerbations: Advances and Future Perspectives
por: Papiris, Spyros A., et al.
Publicado: (2022)

Atractylenolide I Ameliorates Acetaminophen-Induced Acute Liver Injury via the TLR4/MAPKs/NF-κB Signaling Pathways
por: Du, Zhongyan, et al.
Publicado: (2022)

Inhibition of fucosylation by 2-fluorofucose attenuated acetaminophen-induced liver injury via its anti-inflammation and anti-oxidative stress effects
por: Liu, Zhaoguo, et al.
Publicado: (2022)

Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib
por: Shaker, Mohamed E., et al.
Publicado: (2023)

Baseline lymphocyte and cholinesterase levels may be the predictors of chronic herbal drug–induced liver injury
por: Zeng, Zhan, et al.
Publicado: (2022)

Editorial: Drug Repositioning: Current Advances and Future Perspectives
por: Nishimura, Yuhei, et al.
Publicado: (2018)

Corrigendum: Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib
por: Shaker, Mohamed E., et al.
Publicado: (2023)

Acetaminophen: Beyond Pain and Fever-Relieving
por: Blough, Eric R., et al.
Publicado: (2011)

Mitochondrial–Lysosomal Axis in Acetaminophen Hepatotoxicity
por: Moles, Anna, et al.
Publicado: (2018)

Effects of C2-Ceramide and Oltipraz on Hepatocyte Nuclear Factor-1 and Glutathione S-Transferase A1 in Acetaminophen-Mediated Acute Mice Liver Injury
por: Ma, Xin, et al.
Publicado: (2018)

Editorial: Drug development of herbal medicines: Regulatory perspectives
por: Bilia, Anna Rita, et al.
Publicado: (2022)

Acetaminophen Protein Adducts in Hospitalized Children Receiving Multiple Doses of Acetaminophen
por: Jiang, Sibo, et al.
Publicado: (2019)

Recent Advances in Traditional Chinese Medicine for Treatment of Podocyte Injury
por: Yao, Tianwen, et al.
Publicado: (2022)

E3 Ubiquitin Ligase in Anticancer Drugdsla Resistance: Recent Advances and Future Potential
por: Liu, Yuanqi, et al.
Publicado: (2021)

Editorial: Phytochemicals in cancer prevention and therapeutics: Current advancement and future perspective
por: Pore, Subrata Kumar, et al.
Publicado: (2023)

Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
por: Zhang, Li, et al.
Publicado: (2020)

Chronic Drug-Induced Liver Injury: Updates and Future Challenges
por: Wang, Qiaoling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_00e091rqhog0c9avch2a4oe8qd